Représentations croisées sur l’alimentation et la dénutrition chez les patients atteints de cancer : résultats de l’étude NutriCancer2012

Raynard, Bruno; Hébuterne, Xavier; Goldwasser, François; Hssain, Ali Ait; Longeras, Pascale Dubray; Barthélémy, Philippe; Rosso, Edoardo; Phoutthasang, Valérie; Bories, Camille; Digue, Laurence; Laharie, David; Desport, Jean‐Claude; Falkowski, Sabrina; Guily, Jean Lacau Saint; Gyan, Emmanuel

doi:10.1016/j.bulcan.2017.09.014

Cited by 6 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite extensive recognition that malnutrition is a critical predictor of toxicity and outcome in patients with cancer, physcians underestimate the influence of malnutrition-associated symptoms on the quality of care [30]. Lack of human resources, better nutrition training, the creation of nutrition teams to routinely perform nutritional screening have been suggested to optimize management and improve efficacy during cancer treatments [42,43]. In a recent consensus nutritional approach for cancer patients in Spain, experts agreed that multidisciplinary action protocols that include nutritional and/or sarcopenia screening are necessary to be develop in oncology clinics, and that nursing staff should routinely perform nutritional screening before starting cancer treatment [44].…”

Section: Discussionmentioning

confidence: 99%

Prevalence and Impact of Nutritional Risk and Malnutrition in Gastrointestinal Surgical Oncology Patients: A Prospective, Observational, Multicenter and Exploratory Study

Póveda¹,

Suárez-de-la-Rica²,

Cáncer-Minchot³

et al. 2023

Preprint

View full text Add to dashboard Cite

A prospective, observational, multicenter, and exploratory study was conducted in 469 gastrointestinal cancer patients undergoing elective surgery. The Malnutrition Universal Screening Tool (MUST) and the Global Leadership Initiative on Malnutrition (GLIM) criteria were used to assess nutritional risk. On admission, 17.9% and 21.1% of patients were at moderate (MUST score 1) and severe (MUST score ≥ 2) nutritional risk, respectively. GLIM criteria used in patients with MUST score ≥ 2 showed moderate malnutrition in 35.3% of patients and severe in 64.6%. Forty-seven percent of patients with MUST score ≥ 2 on admission had the same score at discharge, and 20.7% with MUST score 0 had moderate/severe risk at discharge. Small bowel, esophageal and gastric cancer, and diabetes were predictors of malnutrition on admission. Complications were significantly higher among patients with MUST score 1 or ≥ 2 either on admission (p = 0.001) or at discharge (p &lt; 0.0001). In patients who received nutritional therapy (n = 231), 43% continued to have moderate/severe nutritional risk on discharge, and 54% of those with MUST ≥ 2 on admission maintained this score at discharge. In gastrointestinal cancer patients undergoing elective surgery, there is an urgent need for improving nutritional risk screening before and after surgery, as well as improving nutritional therapy during hospitalization

show abstract

Section: Discussionmentioning

confidence: 99%

Prevalence and Impact of Nutritional Risk and Malnutrition in Gastrointestinal Surgical Oncology Patients: A Prospective, Observational, Multicenter and Exploratory Study

Póveda¹,

Suárez-de-la-Rica²,

Cáncer-Minchot³

et al. 2023

Preprint

View full text Add to dashboard Cite

show abstract

“…Despite extensive recognition that malnutrition is a critical predictor of toxicity and outcome in patients with cancer, physicians underestimate the influence of malnutrition-associated symptoms on the quality of care [ 30 ]. Lack of human resources, better nutrition training, and the creation of nutrition teams to routinely perform nutritional screening have been suggested to optimize management and improve efficacy during cancer treatments [ 42 , 43 ]. In a recent consensus nutritional approach for cancer patients in Spain, experts agreed that multidisciplinary action protocols that include nutritional and/or sarcopenia screening need to be developed in oncology clinics, and that nursing staff should routinely perform nutritional screening before starting cancer treatment [ 44 ].…”

Section: Discussionmentioning

confidence: 99%

The Prevalence and Impact of Nutritional Risk and Malnutrition in Gastrointestinal Surgical Oncology Patients: A Prospective, Observational, Multicenter, and Exploratory Study

et al. 2023

View full text Add to dashboard Cite

A prospective, observational, multicenter, and exploratory study was conducted in 469 gastrointestinal cancer patients undergoing elective surgery. The Malnutrition Universal Screening Tool (MUST) and the Global Leadership Initiative on Malnutrition (GLIM) criteria were used to assess nutritional risk. On admission, 17.9% and 21.1% of patients were at moderate (MUST score 1) and severe (MUST score ≥ 2) nutritional risk, respectively. The GLIM criteria used in patients with a MUST score ≥ 2 showed moderate malnutrition in 35.3% of patients and severe in 64.6%. Forty-seven percent of patients with a MUST score ≥ 2 on admission had the same score at discharge, and 20.7% with a MUST score 0 had moderate/severe risk at discharge. Small bowel, esophageal, and gastric cancer and diabetes were predictors of malnutrition on admission. Complications were significantly higher among patients with a MUST score 1 or ≥2 either on admission (p = 0.001) or at discharge (p < 0.0001). In patients who received nutritional therapy (n = 231), 43% continued to have moderate/severe nutritional risk on discharge, and 54% of those with MUST ≥ 2 on admission maintained this score at discharge. In gastrointestinal cancer patients undergoing elective surgery, there is an urgent need for improving nutritional risk screening before and after surgery, as well as improving nutritional therapy during hospitalization.

show abstract

The prevalence of CT-defined low skeletal muscle mass in patients with metastatic cancer: a cross-sectional multicenter French study (the SCAN study)

Raynard

Pigneur

Palma

et al. 2021

Support Care Cancer

Self Cite

View full text Add to dashboard Cite

Background Cachexia, characterized by involuntary muscle mass loss, negatively impacts survival outcomes, treatment tolerability, and functionality in cancer patients. However, there is a limited appreciation of the true prevalence of low muscle mass due to inconsistent diagnostic methods and limited oncologist awareness. Methods Twenty-nine French healthcare establishments participated in this cross-sectional study, recruiting patients with those metastatic cancers most frequently encountered in routine practice (colon, breast, kidney, lung, prostate). The primary outcome was low skeletal muscle mass prevalence, as diagnosed by estimating the skeletal mass index (SMI) in the middle of the third-lumbar vertebrae (L3) level via computed tomography (CT). Other objectives included an evaluation of nutritional management, physical activity, and toxicities related to ongoing treatment. Results Seven hundred sixty-six patients (49.9% males) were enrolled with a mean age of 65.0 years. Low muscle mass prevalence was 69.1%. Only one-third of patients with low skeletal muscle mass were receiving nutritional counselling and only 28.4% were under nutritional management (oral supplements, enteral or parenteral nutrition). Physicians highly underdiagnosed those patients identified with low skeletal muscle mass, as defined by the primary objective, by 74.3% and 44.9% in obese and non-obese patients, respectively. Multivariate analyses revealed a lower risk of low skeletal muscle mass for females (OR: 0.22, P < 0.01) and those without brain metastasis (OR: 0.34, P < 0.01). Low skeletal muscle mass patients were more likely to have delayed treatment administration due to toxicity (11.9% versus 6.8%, P = 0.04). Conclusions There is a critical need to raise awareness of low skeletal muscle mass diagnosis among oncologists, and for improvements in nutritional management and physical therapies of cancer patients to curb potential cachexia. This calls for cross-disciplinary collaborations among oncologists, nutritionists, physiotherapists, and radiologists.

show abstract

Représentations croisées sur l’alimentation et la dénutrition chez les patients atteints de cancer : résultats de l’étude NutriCancer2012

Cited by 6 publications

References 19 publications

Prevalence and Impact of Nutritional Risk and Malnutrition in Gastrointestinal Surgical Oncology Patients: A Prospective, Observational, Multicenter and Exploratory Study

Prevalence and Impact of Nutritional Risk and Malnutrition in Gastrointestinal Surgical Oncology Patients: A Prospective, Observational, Multicenter and Exploratory Study

The Prevalence and Impact of Nutritional Risk and Malnutrition in Gastrointestinal Surgical Oncology Patients: A Prospective, Observational, Multicenter, and Exploratory Study

The prevalence of CT-defined low skeletal muscle mass in patients with metastatic cancer: a cross-sectional multicenter French study (the SCAN study)

Contact Info

Product

Resources

About